Boston Scientific 2001 Spending Spree Yields Returns As Stent Sales Decline
This article was originally published in The Gray Sheet
Executive Summary
The top-line growth resulting from a string of acquisitions in the first half of 2001 helped Boston Scientific offset a decline in its coronary stent business during the second quarter of 2002